MariMed Inc (MRMD): Level 2 games going on multiple trades g...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	28
Posts	3098
Boards Moderated	0
Alias Born	07/08/2010

Stoquer1

Re: ShadowSpy69 post# 3087

Tuesday, 09/22/2020 10:25:17 AM

Tuesday, September 22, 2020 10:25:17 AM

Level 2 games going on multiple trades go thru @.165 and no change in the ask. All hidden orders, yesterdays volume should have moved this thing up, still think its being accumulated and being held down.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent MRMD News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:30:47 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/11/2024 09:05:01 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:02:55 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:06:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 10:03:37 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 09:11:11 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:07:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:06:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 11:35:02 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 09:24:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 09:17:46 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 10:29:20 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 06:45:17 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2023 09:13:09 PM

More MRMD News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover